159 related articles for article (PubMed ID: 34507373)
21. Refractory coeliac disease: a window between coeliac disease and enteropathy associated T cell lymphoma.
Mulder CJ; Wahab PJ; Moshaver B; Meijer JW
Scand J Gastroenterol Suppl; 2000; (232):32-7. PubMed ID: 11232488
[TBL] [Abstract][Full Text] [Related]
22. Clinical staging and survival in refractory celiac disease: a single center experience.
Rubio-Tapia A; Kelly DG; Lahr BD; Dogan A; Wu TT; Murray JA
Gastroenterology; 2009 Jan; 136(1):99-107; quiz 352-3. PubMed ID: 18996383
[TBL] [Abstract][Full Text] [Related]
23. Celiac Crisis in Refractory Celiac Disease Type I with Neurological Manifestations: A Diagnostic Dilemma.
Rai AA; Butt MO; Laeeq SM; Abbas Z; Luck NH; Hassan SM; Tasneem AA; Mubarak M
J Coll Physicians Surg Pak; 2015 Oct; 25 Suppl 2():S134-6. PubMed ID: 26522202
[TBL] [Abstract][Full Text] [Related]
24. Successful novel use of tofacitinib for type II refractory coeliac disease.
Grewal JK; Kassardjian A; Weiss GA
BMJ Case Rep; 2022 Apr; 15(4):. PubMed ID: 35418371
[TBL] [Abstract][Full Text] [Related]
25. DNAM-1 mediates epithelial cell-specific cytotoxicity of aberrant intraepithelial lymphocyte lines from refractory celiac disease type II patients.
Tjon JM; Kooy-Winkelaar YM; Tack GJ; Mommaas AM; Schreurs MW; Schilham MW; Mulder CJ; van Bergen J; Koning F
J Immunol; 2011 Jun; 186(11):6304-12. PubMed ID: 21525383
[TBL] [Abstract][Full Text] [Related]
26. Presentation and long-term follow-up of refractory celiac disease: comparison of type I with type II.
Malamut G; Afchain P; Verkarre V; Lecomte T; Amiot A; Damotte D; Bouhnik Y; Colombel JF; Delchier JC; Allez M; Cosnes J; Lavergne-Slove A; Meresse B; Trinquart L; Macintyre E; Radford-Weiss I; Hermine O; Brousse N; Cerf-Bensussan N; Cellier C
Gastroenterology; 2009 Jan; 136(1):81-90. PubMed ID: 19014942
[TBL] [Abstract][Full Text] [Related]
27. Increased IgA glycoprotein-2 specific antibody titres in refractory celiac disease.
Gross S; Bakker SF; van Bodegraven AA; van Hoogstraten IM; Gelderman KA; Bouma G; Mulder CJ; von Blomberg BM; Bontkes HJ
J Gastrointestin Liver Dis; 2014 Jun; 23(2):127-33. PubMed ID: 24949603
[TBL] [Abstract][Full Text] [Related]
28. Azathioprine and prednisone combination therapy in refractory coeliac disease.
Goerres MS; Meijer JW; Wahab PJ; Kerckhaert JA; Groenen PJ; Van Krieken JH; Mulder CJ
Aliment Pharmacol Ther; 2003 Sep; 18(5):487-94. PubMed ID: 12950421
[TBL] [Abstract][Full Text] [Related]
29. The management of complicated celiac disease.
Al-toma A; Verbeek WH; Mulder CJ
Dig Dis; 2007; 25(3):230-6. PubMed ID: 17827946
[TBL] [Abstract][Full Text] [Related]
30. The incidence and clinical spectrum of refractory celiac disease in a north american referral center.
Roshan B; Leffler DA; Jamma S; Dennis M; Sheth S; Falchuk K; Najarian R; Goldsmith J; Tariq S; Schuppan D; Kelly CP
Am J Gastroenterol; 2011 May; 106(5):923-8. PubMed ID: 21468013
[TBL] [Abstract][Full Text] [Related]
31. Update on the management of refractory coeliac disease.
Al-Toma A; Verbeek WH; Mulder CJ
J Gastrointestin Liver Dis; 2007 Mar; 16(1):57-63. PubMed ID: 17410290
[TBL] [Abstract][Full Text] [Related]
32. Cellular and molecular bases of refractory celiac disease.
Soderquist CR; Bhagat G
Int Rev Cell Mol Biol; 2021; 358():207-240. PubMed ID: 33707055
[TBL] [Abstract][Full Text] [Related]
33. Refractory coeliac disease.
Daum S; Cellier C; Mulder CJ
Best Pract Res Clin Gastroenterol; 2005 Jun; 19(3):413-24. PubMed ID: 15925846
[TBL] [Abstract][Full Text] [Related]
34. Open-Capsule Budesonide for Refractory Celiac Disease.
Mukewar SS; Sharma A; Rubio-Tapia A; Wu TT; Jabri B; Murray JA
Am J Gastroenterol; 2017 Jun; 112(6):959-967. PubMed ID: 28323276
[TBL] [Abstract][Full Text] [Related]
35. Current and novel therapeutic strategies in celiac disease.
Kurada S; Yadav A; Leffler DA
Expert Rev Clin Pharmacol; 2016 Sep; 9(9):1211-23. PubMed ID: 27322016
[TBL] [Abstract][Full Text] [Related]
36. Refractory celiac disease: an unusual disease in a Chinese patient.
Lok KH; Yeung HC; Li KF; Li KK; Szeto ML
J Dig Dis; 2008 Nov; 9(4):238-40. PubMed ID: 18959597
[TBL] [Abstract][Full Text] [Related]
37. Aberrant T-lymphocytes in refractory coeliac disease are not strictly confined to a small intestinal intraepithelial localization.
Verbeek WH; von Blomberg BM; Coupe VM; Daum S; Mulder CJ; Schreurs MW
Cytometry B Clin Cytom; 2009 Nov; 76(6):367-74. PubMed ID: 19444812
[TBL] [Abstract][Full Text] [Related]
38. Increase in neuroendocrine cells in the duodenal mucosa of patients with refractory celiac disease.
Di Sabatino A; Giuffrida P; Vanoli A; Luinetti O; Manca R; Biancheri P; Bergamaschi G; Alvisi C; Pasini A; Salvatore C; Biagi F; Solcia E; Corazza GR
Am J Gastroenterol; 2014 Feb; 109(2):258-69. PubMed ID: 24394748
[TBL] [Abstract][Full Text] [Related]
39. High Smad7 sustains inflammatory cytokine response in refractory coeliac disease.
Sedda S; De Simone V; Marafini I; Bevivino G; Izzo R; Paoluzi OA; Colantoni A; Ortenzi A; Giuffrida P; Corazza GR; Vanoli A; Di Sabatino A; Pallone F; Monteleone G
Immunology; 2017 Mar; 150(3):356-363. PubMed ID: 27861825
[TBL] [Abstract][Full Text] [Related]
40. Immunophenotypic Spectrum and Genomic Landscape of Refractory Celiac Disease Type II.
Soderquist CR; Lewis SK; Gru AA; Vlad G; Williams ES; Hsiao S; Mansukhani MM; Park DC; Bacchi CE; Alobeid B; Green PH; Bhagat G
Am J Surg Pathol; 2021 Jul; 45(7):905-916. PubMed ID: 33544565
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
